Phio Pharmaceuticals Corp. (PHIO): Net Income
-$8.70M
Year ended 2025-12-31
-$12.90M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$8.70M | n/m | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | -$7.15M | n/m | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | -$10.83M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$11.48M | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$13.29M | n/m | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | -$8.79M | n/m | 2022-03-22, From 2020-01-01 |
| 2019-12-31 | -$8.91M | n/m | 2021-03-25, From 2019-01-01 |
| 2018-12-31 | -$7.36M | n/m | 2020-03-26, From 2018-01-01 |
| 2017-12-31 | -$12.45M | n/m | 2019-03-27, From 2017-01-01 |
| 2016-12-31 | -$8.99M | n/m | 2018-03-26, From 2016-01-01 |
| 2015-12-31 | -$10.22M | n/m | 2017-03-30, From 2015-01-01 |
| 2014-12-31 | -$8.80M | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | -$20.93M | n/m | 2015-03-30, From 2013-01-01 |
| 2012-12-31 | -$12.88M | n/m | 2014-03-28, From 2012-01-01 |
| 2011-12-31 | -$2.54M | n/m | 2014-03-28, From 2011-01-01 |
| 2010-12-31 | -$11.99M | n/m | 2014-03-28, From 2010-01-01 |
| 2009-12-31 | -$18.39M | n/m | 2014-03-28, From 2009-01-01 |
| 2008-12-31 | -$14.37M | n/m | 2014-03-28, From 2008-01-01 |
| 2007-12-31 | -$10.99M | n/m | 2014-03-28, From 2007-01-01 |
| 2006-12-31 | -$2.40M | n/m | 2014-03-28, From 2006-01-01 |
| 2005-12-31 | -$2.21M | n/m | 2014-03-28, From 2005-01-01 |
| 2004-12-31 | -$3.27M | n/m | 2014-03-28, From 2004-01-01 |
| 2003-12-31 | -$89.0K | n/a | 2014-03-28, From 2003-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | 2025-12-31 | -$8.70M | n/m |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | -$7.49M | n/m |
| BriaCell Therapeutics Corp. (BCTX) | 2025-07-31 | -$26.31M | n/m |
| Annovis Bio, Inc. (ANVS) | 2025-12-31 | -$28.85M | n/m |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | -$7.91M | n/m |
| Moleculin Biotech, Inc. (MBRX) | 2025-12-31 | -$33.56M | n/m |
| Jyong Biotech Ltd. (MENS) | 2025-12-31 | -$4.67M | n/m |
| Nexentis Technologies Inc. (NXTS) | 2025-12-31 | -$4.00M | n/m |
| Quoin Pharmaceuticals Ltd. (QNRX) | 2025-12-31 | -$15.80M | n/m |
Compare PHIO, EMMA, BCTX, ANVS side by side · Screen every company in Pharmaceutical Preparations ↗